Vertex Pharmaceuticals Inc

Go to Vertex Pharmaceuticals Inc Website

$462.13

5.26 (1.15%)
Live
Previous Close

$462.13

Day Range

$453.51 - $464.225

Previous Day Range

$455.45 - $470.59

Market Cap

$118.7 billion USD

Day Vol.

1.9 million

Previous Day Vol.

1.5 million

Currency

USD

Primary Exchange

Nasdaq

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, whe...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

The article discusses two potential growth stocks for long-term investment: Vertex Pharmaceuticals and Lululemon Athletica. Vertex shows promise in rare disease drug development, while Lululemon faces short-term challenges but demonstrates international market growth potential.

Related tickers: VRTX, LULU.

Read Full Article

Market analysis predicts growth in chronic pain associated with painful diabetic neuropathy treatments from 2025-2034, driven by emerging therapies and increased healthcare spending across seven major markets.

Related tickers: VRTX.

Read Full Article
Trending Tickers

Please sign in to view